Navigation Links
Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference

CANTON, Mass. and SAN DIEGO, Oct. 27 /PRNewswire/ -- Organogenesis, Inc. Chief Medical Officer Dr. Damien Bates will speak on the first night of the prestigious TEDMED medical innovation conference beginning today in San Diego, Calif. Dr. Bates' speech "Where Does Replacement Skin Come From?" will outline developments in the emerging and promising field of Regenerative Medicine and discuss the transformation of patient lives.

The field of regenerative medicine has now reached the stage of translating groundbreaking science into viable product offerings. Organogenesis was the first company to successfully commercialize and mass produce living regenerative medicine products - reaching hundreds of thousands of patients in the U.S. and around the world. Its flagship product, Apligraf®, was the first regenerative medicine product to have received U.S. Food and Drug Administration (FDA) approvals to close both diabetic foot ulcers and venous leg ulcers.

Damien Bates, MD, PhD, FRACS (Plast.), is a practicing board certified plastic and reconstructive surgeon with over 12 years of clinical experience in both the U.S. and Australia. Dr. Bates holds an MD from the University of Sydney and a PhD in developmental biology from the University of Melbourne.


The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital. Together, this encompasses more than twenty percent of America's GNP while touching everyone's life around the globe. TEDMED 2009 will take place October 27-30 in San Diego, Calif. For more information, visit

About Regenerative Medicine

A new frontier in healthcare, regenerative medicine utilizes living human cells to repair or replace body tissue damaged by injury, disease or even the natural aging process. Regenerative medicine is a multidisciplinary field which brings together biology, medicine, and engineering to empower scientists to grow living cells, tissues and organs in the laboratory, and to safely implant them into the human body for the purposes of healing.

About Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing, oral regeneration and bio-surgery. The company's mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. For more information, visit

SOURCE Organogenesis, Inc.

SOURCE Organogenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
2. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
3. Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
4. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
5. Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis New Headquarters
6. Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
7. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
8. Professor K. C. Nicolaou Speaks at WuXi AppTec
9. Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at Persuasive Technologies 2009 Conference and Voices That Matter Web Design Conference
10. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
11. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
Post Your Comments:
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):